In conclusion, in this randomized small study we show that, in T2DM patients, insulin pump therapy achieves a similar medium-term glycemic control compared to MDI, without any significant adverse effect on the cardiovascular system. This evidence concerns the gene INS and type 2 diabetes mellitus.